Biopharmaceutical Company
Appears in 1 story
Advancing MF-300 through Phase 2b trials; FDA alignment achieved on trial design
Since 1743, when surgeon William Hunter declared that damaged cartilage 'is never recovered,' medicine has accepted this as biological fact. Nearly 300 years later, Stanford researchers have demonstrated something different: an injectable drug that blocks a single protein can regrow cartilage in aging mice—and in human tissue samples taken from knee replacement patients.
Updated Feb 17
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
